Skip to main content

Advertisement

Fig. 2 | Trials

Fig. 2

From: Comparative study of the inhibitory effect on bone erosion progression with denosumab treatment and conventional treatment in rheumatoid arthritis patients: study protocol for an open-label randomized controlled trial by HR-pQCT

Fig. 2

Treatment schedule and outcome measures. Abbreviations: BMD bone mineral density, csDMARD conventional synthetic disease-modifying anti-rheumatic drug, DXA dual-energy x-ray absorptiometry, HR-pQCT high-resolution peripheral quantitative computed tomography, MRI magnetic resonance imaging.

Back to article page